BELLEROPHON THERAPEUTICS, INC.
BELLEROPHON THERAPEUTICS, INC. is a registered legal entity registered in United States under 0101035881, and its current status with New Jersey Division of Revenue & Enterprise Services is active. The company was incorporated on 18 February 2015 and lists its registered address as WARREN, United States. 5 shareholders are on record for BELLEROPHON THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last updated on 22 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for BELLEROPHON THERAPEUTICS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group, Inc. (The), holding 12.4% — the largest recorded stake — followed by Acadian Asset Management. LLC at 9.1%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 33 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group, Inc. (The) | 12.4% | New Jersey Division of Revenue & Enterprise Services | |
| Acadian Asset Management. LLC | 9.1% | New Jersey Division of Revenue & Enterprise Services | |
| Vanguard Total Stock Market Index Fund | 7.2% | New Jersey Division of Revenue & Enterprise Services | |
| Renaissance Technologies, LLC | 7.2% | New Jersey Division of Revenue & Enterprise Services | |
| Wells Fargo & Company | 6.9% | New Jersey Division of Revenue & Enterprise Services |
Officers
1
One officer is currently on record for BELLEROPHON THERAPEUTICS, INC., filed with New Jersey Division of Revenue & Enterprise Services. Craig R. Jalbert Cira serves as President, Treasurer, Secretary, Principal Executive, Financial & Accounting Officer And Director.
Management authority at BELLEROPHON THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns BELLEROPHON THERAPEUTICS, INC.?
Five shareholders are currently on record for BELLEROPHON THERAPEUTICS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group, Inc. (The), holding 12.4% — the largest recorded stake — followed by Acadian Asset Management. LLC at 9.1%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is BELLEROPHON THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for BELLEROPHON THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does BELLEROPHON THERAPEUTICS, INC. have on record?
5 shareholders are shown on record for BELLEROPHON THERAPEUTICS, INC.. The register reports 33 in total; only the top 5 by holding are shown here.
What is BELLEROPHON THERAPEUTICS, INC.'s company registration number?
BELLEROPHON THERAPEUTICS, INC.'s registration number is 0101035881, filed with New Jersey Division of Revenue & Enterprise Services in United States. Its current status on the register is active.
Is BELLEROPHON THERAPEUTICS, INC. still an active company?
BELLEROPHON THERAPEUTICS, INC.'s status on New Jersey Division of Revenue & Enterprise Services is listed as active.
When was BELLEROPHON THERAPEUTICS, INC. incorporated?
BELLEROPHON THERAPEUTICS, INC. was incorporated on 18 February 2015, according to New Jersey Division of Revenue & Enterprise Services.
What is BELLEROPHON THERAPEUTICS, INC.'s registered address?
The registered address on file for BELLEROPHON THERAPEUTICS, INC. is WARREN, United States.
Who are the officers/directors of BELLEROPHON THERAPEUTICS, INC.?
One officer is currently on record for BELLEROPHON THERAPEUTICS, INC., filed with New Jersey Division of Revenue & Enterprise Services. Craig R. Jalbert Cira serves as President, Treasurer, Secretary, Principal Executive, Financial & Accounting Officer And Director. Management authority at BELLEROPHON THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to BELLEROPHON THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from New Jersey Division of Revenue & Enterprise Services. Zavia's monitoring API can track changes to BELLEROPHON THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access BELLEROPHON THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like BELLEROPHON THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last synced on 22 October 2026.